Introduction
Direct reprogramming of differentiated mature cells into each other is of great importance as it provides a short cut to create a cell line of interest while eliminating the necessity for an intermediate pluripotent state. Somatic cells can be directly reprogrammed into each other by either using small molecules (Hu et al., 2015; Cao et al., 2016) or expressing the master transcription factors ectopically in target cells (Caiazzo et al., 2011; Su et al., 2014) . Viral vector systems are common molecular tools to express master transcription factor genes in reprogramming studies as the viral vectors can transfect a wide variety of mammalian cell types and can highly express the genes of interest that they carry with low toxicity in the transfected cells (Li et al., 2013) . However, the use of viral vectors in medical applications presents some concerns because of their potential to alter the host genome by random integration of viral genes into the host genome (Fischer et al., 2011) . Immunogenicity produced by viral proteins is another problem limiting the use of viral vectors (Thacker et al., 2009) . Retroviral vectors do integrate into the host DNA to replicate and express the genes that they carry. Unlike retroviruses, adenoviruses remain in the cytoplasm of the transfected cells as a separate plasmid particle and do not need to integrate into the host DNA for expression of their genes. However, there is always a risk of adenoviral DNA integration into the host DNA by recombination. Depending on the integration site, viral DNA fragments integrated into host DNA can cause malignancy. The risk of host genome alteration and its possible carcinogenic effects due to viral vectors made scientists look for a new approach that is not a viral or DNA-based system to carry and express the genes of interest in the cells to be reprogrammed (Li et al., 2013) . Transfection of in vitrosynthesized mRNAs of master transcription factors into target cells is an alternative strategy for gene delivery. mRNA transfection can be considered a safer method compared to DNA-based vectors as there is no chance for recombination of mRNA into the DNA. Synthetic mRNA transfection is also more advantageous than recombinant protein delivery as it avoids the time and cost-consuming of recombinant protein production, purification, and delivery. After their transfection synthetic mRNAs can be directly translated into functional proteins in the cytoplasm of recipient cells. They will also acquire proper posttranslational protein modifications, which will result in production of more functional proteins compared to those produced in bacterial expression systems. There are various studies showing that in vitro-synthesized mRNAs can be efficiently delivered into target cells and provide a proper translation of their corresponding proteins (Boczkowski et al., 2009; Plews et al., 2010; Warren et al., 2010; Yakubov et al., 2010) . However, after transfection, in vitro-synthesized mRNAs are recognized as viral RNAs by host cells. As the result, a strong interferon reaction is initiated in host cells, which eventually results in cell arrest and/or cell death. To escape from this innate immune system of the host cells some modifications should be applied during in vitro transcription (IVT) of synthetic mRNAs. For instance, i) use of pseudouridine (psi) (Kariko et al., 2008) and 5-methylcytidine (5mC) instead of uridine and cytidine respectively during the IVT reaction, ii) phosphatase treatment of synthesized mRNAs to remove free phosphate groups from the 5′ end of uncapped mRNAs after the IVT reaction, and iii) adding B18R recombinant protein (a type-I interferon binding protein that inhibits IFN response) in the culture medium of host cells are some of these modifications.
Pancreatic beta cells are a medically important cell type because their loss due to an auto-immune attack causes diabetes, a serious metabolic disease characterized by hyperglycemia. Drawbacks of the current treatments of diabetes necessitate creating a new beta cell source. Direct reprogramming of other mature somatic cells into beta cells is an alternative strategy to find a new treatment for diabetes. Production of insulin positive beta-like cells was shown in various studies in which some important pancreatic transcription factor genes such as Pdx1, Ngn3, and MafA were overexpressed in host cells through DNAbased vector systems (Zhou et al., 2008; Akinci et al., 2012; Banga et al., 2012; Yang et al., 2013) .
The aim of the present study was to find a suitable condition to ameliorate glucose dependent insulin secreting pancreatic beta cell generation through mRNA transfection of important pancreatic transcription factors to human mature somatic cells. To achieve our goal, we devoted effort to in vitro synthesize mRNAs of three important human pancreatic transcription factors (Pdx1, Ngn3, and MafA) to be transfected into human skin fibroblast (BJ) cells. We then assessed the transfection by examining the expression of the synthetic mRNAs inside the cells and their translation to the corresponding functional proteins. This study will be a preliminary step to attain our fundamental purpose of beta cell generation betterment. (Table 2) as adapter fragments. Ligation conditions were as follows: 95 °C for 10 s denaturation, 45 °C for 60 s, 50 °C for 60 s, 55 °C for 60 s annealing, and overall 5 cycles were performed. UTRligated cDNAs were amplified by using template primers (Table 2) . PCR conditions were as follows: 98 °C for 30 s initial denaturation, 98 °C for 10 s denaturation, 60 °C for 30 s annealing, 72 °C for 1 min extension, 72 °C for 5 min final extension, and overall 35 cycles were performed. UTRs ligation was visualized by blue light box on agarose gel including GelStar dye. DNA bands at expected size were extracted and purified. Ligation products were cloned into a blunt end vector (pJET1.2/blunt) (Thermo Scientific) and sent to Macrogen Company (Amsterdam, Netherlands) for DNA sequencing. Plasmids carrying UTR-ligated cDNAs were then linearized by SalI digestion. Poly(T) tails were added to the linearized template through a PCR by using tail primers (Table 2 ). PCR conditions were performed. Poly(T) tail addition was visualized by a UV-based gel imaging system on an agarose gel including EtBr. Poly(T) tail-added PCR products were purified with a PCR purification kit.
Materials and methods

In vitro transcription (IVT) reaction
Pdx1, Ngn3, and MafA modified mRNAs were in vitro-transcribed from poly(T) tail added and purified PCR products by using an mMessage mMachine T7 transcription kit (Ambion, Austin, TX, USA). The IVT reaction mixture was prepared as 40 µL including ~1-2 µg of tailed PCR product, Anti Reverse Cap Analog (ARCA, 3′-O-Me-m 7 G(5′)ppp(5′)G) (Trilink, San Diego, CA, USA), GTP, ATP, 5-methylcytidine (5-me-CTP) (Trilink), and pseudouridine (pUTP) (Trilink). The IVT mixture was incubated at 37 °C for 4 h and then was treated with DNase at 37 °C for 15 min. The reaction was purified using a MEGAclear transcription clean up kit (Ambion) as per the manufacturer's directions. The reaction mixture was further treated with Antarctic phosphatase (NEB, Ipswich, MA, USA) at 37 °C for 1 h and purified again. The quality and quantity of the in vitro-transcribed RNAs (IVT RNAs) were measured by NanoDrop spectrophotometer (Thermo Scientific).
Cell culture and transfection with IVT RNAs
Human skin fibroblast (BJ) cells (ATCC, Manassas, VA, USA) were plated (3 × 10 5 /well) in 6-well plates (Corning, Corning, NY, USA) with growth medium comprising high glucose DMEM (Gibco, Waltham, MA, USA), 10% FBS (Gibco), 1X L-glutamine (Gibco), 1X NEAA (Gibco), and 1X antibiotic-antimycotic (Gibco). The next day the cells were transfected with IVT RNAs using lipofectamine (Invitrogen, Carlsbad, CA, USA), which has a cationic liposome formulation. The growth medium was replaced with fresh medium containing 1:2400 B18R (Stemgent, Cambridge, MA, USA) 12 h before transfection. For transfection 3 µg of IVT RNA (30 µL) was mixed with 20 µL of Opti-MEM (Gibco). In a separate tube 15 µL of lipofectamine was mixed with 35 µL of Opti-MEM. Both mixtures were gently mixed together, incubated for 20 min at room temperature, and added to cells dropwise. The growth medium was replaced with fresh medium 6 h after transfection.
Quantitative polymerase chain reaction (qPCR)
RNA isolation was performed 16 h after transfection by using a Purelink RNA mini kit (Invitrogen) according to the manufacturer's directions. cDNAs were reverse transcribed from 2 µg of RNA by using a Maxima first strand cDNA synthesis kit (Thermo Scientific) as per the manufacturer's directions. cDNAs were then analyzed by quantitative PCR in a Light Cycler 96 system (Roche, Basel, Switzerland). The qPCR mixture was prepared as 20 µL comprising KAPA SYBR FAST qPCR master mix (KAPA Biosystems, Wilmington, MA, USA), forward and reverse primers (Table 3) , and ~20 ng of cDNA. qPCR conditions were as follows: 95 °C for 3 min initial denaturation, 95 °C for 10 s denaturation, 60 °C for 30 s annealing/ 
Immunostaining
The cells were fixed 16 h after transfection using 10% formalin (Sigma, St. Louis, MO, USA) for 10 min and were permeabilized with 0.2% Triton X-100/PBS (Sigma) for 15 min. After permeabilization the cells were blocked with 1% BSA in 0.1% Tween-20/PBS for 1 h. The cells were then incubated with primary and secondary antibodies (Table  4) overnight at 4 °C and for 1 h at room temperature, respectively. Finally the cell nuclei were stained with Hoechst (1:500) (Cell Signaling Technologies, Danvers, MA, USA). The cells were then visualized under an Olympus Axiovert inverted microscope (Olympus, Tokyo, Japan). All washing, permeabilization and incubation steps were carried out at room temperature unless indicated otherwise.
Western blotting
Proteins were isolated 16 h after transfection from 10 6 cells that were trypsinized and centrifuged to get a cell pellet. Then 0.5 mL of RIPA buffer (Thermo Scientific) including 5 µL of PIC (Thermo Scientific) was added onto the cell pellet. The cells were vortexed and centrifuged at 15,000 × g for 10 min at 4 °C. The supernatant was removed from the debris and used for further experiments. Next 10% resolving and stacking gels were prepared. Laemmli sample buffer was prepared and mixed with cell extracts at 25 µL final volume. The mixture was boiled for 5 min and then chilled on ice for 2 min. The mixture was loaded to gel and run in a Mini trans-blot cell system (BioRad, Hercules, CA, USA). After overnight blotting at 4 °C, the membrane was incubated with I-Block blocking reagent (Thermo Scientific) for 2 h at room temperature. The membrane was then incubated with primary and secondary antibodies (Table 4 ) diluted in I-Block for 4 h and 1 h, respectively, at 25 °C. SuperSignal West Pico chemiluminescent substrate (Thermo Scientific) was used for signaling and images were obtained by GeneGenome system (Syngene, Cambridge, UK). 2.7. Cell viability assay BJ cells were plated (1.5 × 10 4 /well) into 96-well plates. Each well was transfected with different IVT RNA (Pdx1, Ngn3, and MafA) for 3 days; 110 ng of RNA/well was given to the cells daily. Cells with no treatment and cells treated Figure 1A . To begin with, Pdx1, Ngn3, and MafA ORFs were amplified by PCR and run on an agarose gel. Resulting bands visualized by UV illumination were of expected size: 849 bp for Pdx1, 643 bp for Ngn3, and 1059 bp for MafA ( Figure 1B ). Upon ligation with 5′ UTR (87 bp) and 3′ UTR (119 bp), ligation products were also amplified by PCR and run on an agarose gel. Resulting bands visualized by UV illumination were of expected size: 1055 bp for Pdx1, 849 bp for Ngn3, and 1265 bp for MafA ( Figure 1C ). Poly(T) tails (T 120 ) were then added to ligation products by PCR and run on an agarose gel. Resulting bands visualized by UV illumination verified the addition of 120 bp poly(T) tails to ligation products ( Figure 1D ). UTR ligated ORFs were sent to the Macrogen Company for DNA sequencing. The results demonstrated that all three genes were cloned with high sequence accuracy (99.7% for Pdx1, 99.8% for Ngn3, and 99.9% for MafA). Compared to sequences given in NCBI, in the clones we constructed there are two nucleotide changes in Pdx1 (resulted in no amino acid change), one nucleotide change in Ngn3 (resulted in F199S amino acid change), and 1 nucleotide change in MafA (resulted in no amino acid change).
In vitro transcription and assessment of modified mRNAs of Pdx1, Ngn3, and MafA
The quality and quantity of IVT RNAs were assessed by measuring the OD values using a NanoDrop spectrophotometer. OD values of all IVT RNA samples were within the expected ranges: A260/280 ≥ 1.8 and A260/230 ~ 2 (Figure 2A) , showing the purity of synthesized RNAs. The size of IVT RNA fragments was also assessed by running the samples on a denaturing agarose gel. The results demonstrated that all IVT RNAs were of the expected size: 1175 bp for Pdx1, 969 bp for Ngn3, and 1385 bp for MafA ( Figure 2B ).
Expression of synthesized Pdx1, Ngn3, and MafA mRNAs in human cells
The expression level of IVT RNAs in human BJ fibroblast cells was assessed 16 h after their transfection to the cells. qPCR was performed to see the expression level of exogenous Pdx1, Ngn3, and MafA RNAs. qPCR data ( Figure 3A ) and agarose gel images ( Figure 3B) showed that IVT RNAs can be highly expressed in human cells even 16 h after transfection. 3.4. In vivo translation of synthesized Pdx1, Ngn3, and MafA mRNAs and proper localization of their corresponding proteins in human cells To demonstrate the proper translation of IVT RNAs in human fibroblasts cells, western blot (WB) experiments were performed. The WB results showed that IVT RNAs were translated properly to their corresponding proteins ( Figure 4A) . Moreover, to demonstrate the proper localization of proteins (PDX1, NGN3, and MAFA) translated from IVT RNAs in human fibroblast cells, immunofluorescence (IF) experiments were also performed. IF images demonstrated that all three proteins were located properly in the nucleus, which is the final destination for transcription factors ( Figure 4B ). Both IF and WB results showed that protein translation from IVT RNAs was robust and 16 h after transfection 90.6 ± 2.1% of Pdx1, 85.4 ± 0.2% of Ngn3, and 83.9 ± 3.3% of MafA transfected cells could express the proteins of interest ( Figure 5) . 3.5. Effect of in vitro synthesized Pdx1, Ngn3, and MafA mRNAs on human cell viability Cell viability experiments demonstrated that IVT-modified Pdx1, Ngn3, and MafA RNAs are not toxic for human cells for 3 days (Figure 6 ). In the cell viability experiments resazurin was given to the cells. In metabolically active cells resazurin is converted into resorufin, the absorbance of which can be measured at 560 nm. Dead cells, however, cannot convert resazurin and give lower absorbance at 560 nm. In Figure 6 it can be seen that absorbance of IVT RNA-treated cells is equal to that of control (no IVT RNA treatment) cells and increases over time, indicating that cells are not dying upon IVT RNA transfection but instead keep proliferating.
Discussion
Ectopic expression of master transcription factors enabled direct cell reprogramming for many cell types. Upon discovery of that, especially beta cell reprogramming was studied intensively. Many studies demonstrated that Pdx1, Ngn3, and MafA combination, which are indispensable factors for pancreas and beta cell development, induced beta cell reprogramming and gave promising results. However, the disadvantages of the current vectors, used to ectopically express genes of interest in the target cells, necessitate the development of safer strategies for gene delivery. Construction and transfection of in vitro synthesized mRNAs is safer than viral vector use and reduces the risk of foreign DNA recombination into host genomes, thereby eliminating most of the concerns. In this study we concentrated our efforts on construction and production of in vitro-synthesized mRNAs of important pancreatic transcription factors: Pdx1, Ngn3, and MafA.
First we constructed double strand DNA templates from which synthetic mRNAs will be transcribed in vitro. PCR amplification of ORFs and UTR ligated fragments resulted in nonspecific PCR products in addition to expected fragments ( Figures 1B and 1C ). This was due to limited primer designing opportunity during amplification experiments. Among nonspecific PCR products, the expected fragments were excised out and purified from the agarose gel after electrophoresis. Accuracy of these fragments was verified by DNA sequencing. High accuracy of cloned sequences was achieved due to the fact that high fidelity DNA polymerase enzymes were used in all PCRs.
To demonstrate that DNA constructs that we designed here can produce high quality IVT RNAs as efficient as constructs made by others, we compared IVT RNAs that we made with synthetic GFP mRNA, which was in vitrosynthesized from plasmid pcDNA3.3_NDG, a gift from Derrick Rossi (Addgene plasmid #26820) (Warren et al., 2010) (Figure 2 ). detected as ~30 kDa by using anti-Ngn3 antibody (Abcam, ab38548) . Pinney et al. (2011) also reported NGN3 of the same size by using the same antibody. MAFA protein was detected as ~48 kDa by using anti-MafA antibody (Abcam, ab26405). Kondo et al. (2009) also reported MAFA of the same size by using the same antibody (Kondo et al., 2009 ).
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In conclusion, here we successfully constructed recombinant DNA templates at which Pdx1, Ngn3, and MafA ORFs were ligated to mouse beta globin 3′-UTR and T7 promoter as well as a strong Kozak sequence including 5′-UTR. Synthetic mRNAs with high quality and quantity were in vitro transcribed from these constructs. These IVT RNAs were transfected into the cultured human cells with high efficiency and no toxicity. IVT RNAs were properly translated into their corresponding proteins and localized into the right location. Based on all these results we concluded that DNA templates constructed here can be used to generate in vitro-synthesized RNAs of important pancreatic transcription factors (Pdx1, Ngn3, and MafA) that can be used in further beta cell reprogramming studies.
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